Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Equity (2022 - 2026)

HeartSciences filings provide 5 years of Return on Equity readings, the most recent being 0.02% for Q1 2026.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.02% in Q1 2026 year-over-year; TTM through Jan 2026 was 0.02%, a 0.0% change, with the full-year FY2025 number at 0.02%, down 1.0% from a year prior.
  • Return on Equity hit 0.02% in Q1 2026 for HeartSciences, down from 0.02% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 4.62% in Q2 2023 to a low of 0.16% in Q1 2023.
  • Median Return on Equity over the past 5 years was 0.02% (2024), compared with a mean of 0.29%.
  • Biggest five-year swings in Return on Equity: skyrocketed 461bps in 2023 and later plummeted -463bps in 2024.
  • HeartSciences' Return on Equity stood at 0.03% in 2022, then surged by 266bps to 0.06% in 2023, then tumbled by -128bps to 0.02% in 2024, then tumbled by -59bps to 0.02% in 2025, then fell by -1bps to 0.02% in 2026.
  • The last three reported values for Return on Equity were 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.05% (Q3 2025) per Business Quant data.